Merck Says Vaccine Buyers Must Arbitrate Antitrust Suit
Merck Sharp & Dohme Corp. is doubling down on its bid to arbitrate claims in a proposed class action alleging it violated federal antitrust law by selling overpriced vaccines after the...To view the full article, register now.
Already a subscriber? Click here to view full article